Tackling the Challenges in the Manufacturing of Cell-Based Therapies

CellTherapy-4Angel
While cell-based therapies offer huge potential, significant challenges, including GMP manufacturing, scaling-out, and delivery must be addressed and overcome in order to justify and successfully autologous and allogeneic provides to the market.
Speaker:
Susan McKee, Business Development Manager, Angel Biotechnology

 

Listen to the audio cast here

Leave a Reply